139 related articles for article (PubMed ID: 6200611)
1. No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis.
Pizzocaro G; Monfardini S
J Urol; 1984 Apr; 131(4):677-80. PubMed ID: 6200611
[TBL] [Abstract][Full Text] [Related]
2. Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical Stage II nonseminomatous germinal testis tumors.
Pizzocaro G; Zanoni F; Milani A; Piva L; Salvioni R; Pasi M; Pilotti S; Monfardini S
Cancer; 1984 Mar; 53(6):1363-8. PubMed ID: 6198070
[TBL] [Abstract][Full Text] [Related]
3. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
4. Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.
Motzer RJ; Sheinfeld J; Mazumdar M; Bajorin DF; Bosl GJ; Herr H; Lyn P; Vlamis V
J Clin Oncol; 1995 Nov; 13(11):2700-4. PubMed ID: 7595727
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy in resected stage-II nonseminomatous germ cell tumors of testis. In which cases is it necessary?
Pizzocaro G; Piva L; Salvioni R; Pasi M; Pilotti S; Monfardini S
Eur Urol; 1984; 10(3):151-8. PubMed ID: 6327314
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of patients with stages I and II nonseminomatous testicular cancer.
Fraley EE; Narayan P; Vogelzang NJ; Kennedy BJ; Lange PH
J Urol; 1985 Jul; 134(1):70-3. PubMed ID: 2409301
[TBL] [Abstract][Full Text] [Related]
7. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
[TBL] [Abstract][Full Text] [Related]
8. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy of metastatic stage II nonseminomatous testis tumor.
Weissbach L; Hartlapp JH
J Urol; 1991 Nov; 146(5):1295-8. PubMed ID: 1719242
[TBL] [Abstract][Full Text] [Related]
10. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
11. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.
Culine S; Theodore C; Court BH; Perrin JL; Droz JP
Br J Urol; 1997 Feb; 79(2):258-62. PubMed ID: 9052479
[TBL] [Abstract][Full Text] [Related]
14. Failure of adjuvant chemotherapy in testicular cancer.
Bernstein JI; Freiha F; Breeden J; Torti FM
Cancer; 1987 Oct; 60(8):1729-30. PubMed ID: 2443231
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of testicular cancer: 10-year experience.
Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
[TBL] [Abstract][Full Text] [Related]
16. Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy.
Gelderman WA; Schraffordt Koops H; Sleijfer DT; Oosterhuis JW; Van der Heide JN; Mulder NH; Marrink J; De Bruyn HW; Oldhoff J
J Surg Oncol; 1988 Aug; 38(4):227-32. PubMed ID: 2457771
[TBL] [Abstract][Full Text] [Related]
17. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
18. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
19. Effects of multiple-drug chemotherapy (cis-diammine-dichloroplatinum, bleomycin, and vinblastine) on the maturation of retroperitoneal lymph node metastases of nonseminomatous germ cell tumors of the testis. No evidence for De Novo induction of differentiation.
Oosterhuis JW; Suurmeyer AJ; Sleyfer DT; Koops HS; Oldhoff J; Fleuren G
Cancer; 1983 Feb; 51(3):408-16. PubMed ID: 6185202
[TBL] [Abstract][Full Text] [Related]
20. Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testis.
Pizzocaro G; Nicolai N; Salvioni R
World J Urol; 1994; 12(3):113-9. PubMed ID: 7524920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
